Shares of Mankind Pharma plunged nearly 6 percent on January 24, weighed down by a fall in the company's October-December net profit. The company's bottomline dropped over 16 percent on year in Q3 ...

The 13th International Pharmacy and Medicine Conference (ICPM 2025) revealed the establishment of three new pharmaceutical factories in Sharjah, with a combined investment value exceeding $84 million ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...

Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. One lot of Systane Lubricant Eye Drops Ultra PF ...

Bottles of prescription painkiller OxyContin, 40mg, 20mg and 15mg pills, made by Purdue Pharma L.D. sit on a counter at a local pharmacy, in Provo, Utah, U.S., April 25, 2017. George Frey/Reuters/File ...

The billionaire family that owns Purdue Pharma, maker of the pain medication blamed for helping fuel the nation’s opioid crisis, has agreed to increase payments to settle long-running litigation ...

Bad Bunny‘s new album Debí Tirar Más Fotos is dedicated to “all the Puerto Ricans in the entire world.” On Friday, the reggaetón star unveiled the track list for his upcoming LP and an ...

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a median 4% at the start of this year. The modest size of the annual ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...

Roche’s eye disease therapy Vabysmo narrowly missed a spot on the list of fastest growing drugs this year, the analysts said. Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth ...